 |
 |
 |
 |
300 Longwood Avenue
Boston, MA 02115
(617) 355-6000
|
|
 |
 |
|
Clinical Services (Metabolism Program):
|
|
Research
|
|
Children's Metabolism Program is actively engaged in groundbreaking basic science and clinical research. Below are some examples of research currently being investigated at Children's Hospital Boston:
|
|
- Maternal Phenylketonuria and other Maternal Inborn Errors of Metabolism and their effects on the fetus as well as treatment during pregnancy (these include Maternal Homocystinuria, Maternal Histidinemia, Maternal Cystathioninemia, etc.)
- Pharmacodynamics of tyrosine supplementation in Phenylketonuria
- Role of NTBC as ancillary treatment in Phenylketonuria to address neuropsychological deficits
- Phenylalanine hydroxylase genotypes and degree of hyperphenylalaninemia in non-PKU mild hyperphenylalaninemia
- Sulfur amino acid abnormalities in the methionine catabolic disorders: differentiating Homocystinuria, Isolated Hypermethioninemia, and Transient Hypermethioninemia in the newborn
- Psychosocial factors and support mechanisms in Maternal Phenylketonuria
- Clinical trials for enzyme replacement in lysosomal storage disease
|
|
 |
|
|
 |
 |
 |
 |
 |
 |
The information on this website should not be taken as medical advice, which can only be given to you by your personal health care professional. |
 |
 |
 |
Copyright © Children's Hospital Boston. All rights reserved. |
 |
|
 |
|